Advanced Glycation End Products (AGEs) May Be a Striking Link Between Modern Diet and Health

Steinhart, 2005, The Maillard Reaction. Chemistry, Biochemistry and Implications. By Harry Nursten, Angew. Int. Ed., 44, 7503, 10.1002/anie.200585332

Fogliano, 2018, Dietary Advanced Glycosylation End-Products (dAGEs) and Melanoidins Formed through the Maillard Reaction: Physiological Consequences of their Intake, Annu. Rev. Food Sci. Technol., 9, 271, 10.1146/annurev-food-030117-012441

Thorpe, 2003, Maillard reaction products in tissue proteins: New products and new perspectives, Amino Acids, 25, 275, 10.1007/s00726-003-0017-9

Munch, 1999, Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library, Nat. Biotechnol., 17, 1006, 10.1038/13704

Nowotny, 2018, Dietary advanced glycation end products and their relevance for human health, Ageing Res. Rev., 47, 55, 10.1016/j.arr.2018.06.005

Vasan, 2003, Therapeutic potential of breakers of advanced glycation end product-protein crosslinks, Arch. Biochem. Biophys., 419, 89, 10.1016/j.abb.2003.08.016

Ott, 2014, Role of advanced glycation end products in cellular signaling, Redox Biol., 2, 411, 10.1016/j.redox.2013.12.016

Nass, 2007, Advanced glycation end products, diabetes and ageing, Z. Gerontol. Geriatr., 40, 349, 10.1007/s00391-007-0484-9

Makita, 1992, Immunochemical detection of advanced glycosylation end products in vivo, J. Biol. Chem., 267, 5133, 10.1016/S0021-9258(18)42741-X

Kasper, 2001, Age-related changes in cells and tissues due to advanced glycation end products (AGEs), Arch. Gerontol. Geriatr., 32, 233, 10.1016/S0167-4943(01)00103-0

Ko, S.Y., Ko, H.A., Chu, K.H., Shieh, T.M., Chi, T.C., Chen, H.I., Chang, W.C., and Chang, S.S. (2015). The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer’s Disease. PLoS ONE, 10.

Pinkas, 2016, Advanced Glycation End-Products and Their Receptors: Related Pathologies, Recent Therapeutic Strategies, and a Potential Model for Future Neurodegeneration Studies, Chem. Res. Toxicol., 29, 707, 10.1021/acs.chemrestox.6b00034

Juranek, 2015, Receptor for advanced glycation end-products in neurodegenerative diseases, Rev. Neurosci., 26, 691, 10.1515/revneuro-2015-0003

Ahmed, 2002, Assay of advanced glycation endproducts (AGEs): Surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine-and Nepsilon-(1-carboxyethyl)lysine-modified albumin, Biochem. J., 364, 1, 10.1042/bj3640001

Ravichandran, 2019, Food advanced glycation end products as potential endocrine disruptors: An emerging threat to contemporary and future generation, Environ. Int., 123, 486, 10.1016/j.envint.2018.12.032

Rutkowska, 2016, Polycystic ovary syndrome and environmental toxins, Fertil. Steril., 106, 948, 10.1016/j.fertnstert.2016.08.031

Kutlu, 2016, Dietary glycotoxins and infant formulas, Turk Pediatr., 51, 179, 10.5152/TurkPediatriArs.2016.2543

Nowotny, 2015, Advanced glycation end products and oxidative stress in type 2 diabetes mellitus, Biomolecules, 5, 194, 10.3390/biom5010194

Baye, 2017, Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: A randomised crossover trial, Sci. Rep., 7, 4123, 10.1038/s41598-017-04214-6

Vlassara, 1992, Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications, Proc. Natl. Acad. Sci. USA, 89, 12043, 10.1073/pnas.89.24.12043

Wrobel, 2018, Comparative evaluation of three different ELISA assays and HPLC-ESI-ITMS/MS for the analysis of N(epsilon)-carboxymethyl lysine in food samples, Food Chem., 243, 11, 10.1016/j.foodchem.2017.09.098

Wellner, 2011, Formation of Maillard reaction products during heat treatment of carrots, J. Agric. Food Chem., 59, 7992, 10.1021/jf2013293

Zhou, 2015, Simultaneous analysis of Nε-(carboxymethyl)Lysine and Nε-(carboxyethyl)lysine in foods by ultra-performance liquid chromatography-mass spectrometry with derivatization by 9-fluorenylmethyl chloroformate, J. Food Sci., 80, C207, 10.1111/1750-3841.12744

Zhang, 2003, Rapid determination of advanced glycation end products of proteins using MALDI-TOF-MS and PERL script peptide searching algorithm, J. Biomol. Tech., 14, 224

Ahmed, 2005, Advanced glycation endproducts—Role in pathology of diabetic complications, Diabetes Res. Clin. Pract., 67, 3, 10.1016/j.diabres.2004.09.004

Paul, 1996, Glycation of collagen: The basis of its central role in the late complications of ageing and diabetes, Int. J. Biochem. Cell Biol., 28, 1297, 10.1016/S1357-2725(96)00079-9

Uribarri, J. (2018). Dietary AGE and Their Role in Health and Disease, CRCPress.

Koschinsky, 1997, Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy, Proc. Natl. Acad. Sci. USA, 94, 6474, 10.1073/pnas.94.12.6474

Snelson, M., and Coughlan M., T. (2019). Dietary Advanced Glycation End Products: Digestion, Metabolism and Modulation of Gut Microbial Ecology. Nutrients, 11.

2016, Carboxymethyl-lysine: Thirty years of investigation in the field of age formation, Food Funct., 7, 46, 10.1039/C5FO00918A

Grunwald, 2006, Transepithelial flux of early and advanced glycation compounds across caco-2 cell monolayers and their interaction with intestinal amino acid and peptide transport systems, Br. J. Nutr., 95, 1221, 10.1079/BJN20061793

Hellwig, 2014, N-epsilon-fructosyllysine and n-epsilon-carboxymethyllysine, but not lysinoalanine, are available for absorption after simulated gastrointestinal digestion, Amino Acids., 46, 289, 10.1007/s00726-013-1501-5

Teodorowicz, M., Neerven, J.V., and Savelkoul, H. (2017). Food Processing: The Influence of the Maillard Reaction on Immunogenicity and Allergenicity of Food Proteins. Nutrients, 9.

Bergmann, 2001, Radio fluorination and positron emission tomography (PET) as a new approach to study the in vivo distribution and elimination of the advanced glycation endproducts N-epsilon-carboxymethyllysine (CML) and N-epsilon-carboxyethyllysine (CEL)and N epsilon-carboxyethyllysine (CEL), Nahrung, 45, 182, 10.1002/1521-3803(20010601)45:3<182::AID-FOOD182>3.0.CO;2-Q

He, 1999, Dietary glycotoxins: Inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration, Diabetes, 48, 1308, 10.2337/diabetes.48.6.1308

Poulsen, 2013, Advanced glycation endproducts in food and their effects on health, Food Chem. Toxicol., 60, 10, 10.1016/j.fct.2013.06.052

Guilbaud, A., Niquet-Leridon, C., Boulanger, E., and Tessier, F.J. (2016). How Can Diet Affect the Accumulation of Advanced Glycation End-Products in the Human Body?. Foods, 5.

Uribarri, 2010, Advanced glycation end products in foods and a practical guide to their reduction in the diet, J. Am. Diet. Assoc., 110, 911, 10.1016/j.jada.2010.03.018

Uribarri, 2015, Dietary advanced glycation end products and their role in health and disease, Adv. Nutr., 6, 461, 10.3945/an.115.008433

Henle, 2007, Dietary advanced glycation end products—A risk to human health? A call for an interdisciplinary debate, Mol. Nutr. Food Res., 51, 1075, 10.1002/mnfr.200700067

Cai, 2014, Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans, Proc. Natl. Acad. Sci. USA, 111, 4940, 10.1073/pnas.1316013111

Fishman, 2018, The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: A review, Mol. Med., 24, 59, 10.1186/s10020-018-0060-3

Davis, 2016, Advanced Glycation End Products, Inflammation, and Chronic Metabolic Diseases: Links in a Chain?, Crit. Rev. Food Sci. Nutr., 56, 989, 10.1080/10408398.2012.744738

Li, 2012, Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective, J. Neurol. Sci., 317, 1, 10.1016/j.jns.2012.02.018

Yamagishi, 2016, Pathologic role of dietary advanced glycation end products in cardiometabolic disorders, and therapeutic intervention, Nutrition, 32, 157, 10.1016/j.nut.2015.08.001

Illien-Junger, S., Lu, Y., Qureshi, S.A., Hecht, A.C., Cai, W., Vlassara, H., Striker, G.E., and Iatridis, J.C. (2015). Chronic ingestion of advanced glycation end products induces degenerative spinal changes and hypertrophy in aging pre-diabetic mice. PLoS ONE, 10.

Magalhaes, 2008, Involvement of advanced glycation end products in the pathogenesis of diabetic complications: The protective role of regular physical activity, Eur. Rev. Aging Phys. Act., 5, 17, 10.1007/s11556-008-0032-7

Lo, 2008, Reactive dicarbonyl compounds and 5-(hydroxymethyl)-2-furfural in carbonated beverages containing high fructose corn syrup, Food Chem., 107, 1099, 10.1016/j.foodchem.2007.09.028

Degen, 2012, 1,2-dicarbonyl compounds in commonly consumed foods, J. Agric. Food Chem., 60, 7071, 10.1021/jf301306g

EFSA (European food safety authority) (2012). Update on acrylamide levels in food from monitoring years 2007–2010. EFSA J., 10, 2938–2976.

Mariotti, 2013, Are Chileans exposed to dietary furan?, Food Addit. Contam. Part A, 10, 1715, 10.1080/19440049.2013.815807

Aguirre, D.B., Corradini, M.G., Candogan, K., and Barbosa-Canovas, G.V. (2016). High pressure processing in combination with high temperature and other preservation factors. High Pressure Processing of Food, Springer.

1997, Determination of free and total furfural compounds in infant milk formulas by high-performance liquid chromatography, J. Agric. Food Chem., 45, 2128, 10.1021/jf960770n

Prosser, 2019, N(epsilon)-carboxymethyllysine in nutritional milk formulas for infants, Food Chem., 274, 886, 10.1016/j.foodchem.2018.09.069

Samson, 2014, Metabolic syndrome, Endocrinol. Metab. Clin. N. Am., 43, 1, 10.1016/j.ecl.2013.09.009

Han, 2017, Long-term and late treatment consequences: Endocrine and metabolic effects, Curr. Opin. Support Palliat. Care, 11, 205, 10.1097/SPC.0000000000000289

Gupta, 2016, Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children, Horm. Res. Paediatr., 85, 291, 10.1159/000444053

Hsu, 2019, Protein Glycation by glyoxal promotes amyloid formation by islets amyloid polypeptide, Biophys. J., 116, 2304, 10.1016/j.bpj.2019.05.013

Hanyu, 2019, Diabetes –related Dementia, Diabetes Mellit., 1128, 147, 10.1007/978-981-13-3540-2_8

Chou, P.S., Wu, M.N., Yang, C.C., Shen, C.T., and Yang, Y.H. (2019). Effect of advanced glycation end products on the progression of Alzheimer’s disease. J. Alzheimers Dis.

Kouidrat, 2015, Advanced glycation end products and schizophrenia: A systematic review, J Psychiatr. Res., 66, 112, 10.1016/j.jpsychires.2015.04.023

Clatici, 2017, Glycation: Implication in perceived age and dermatology, Rom. J. Clin. Experi. Dermatol., 4, 114

Kirstein, 1990, Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging, Proc. Natl. Acad. Sci. USA, 87, 9010, 10.1073/pnas.87.22.9010

Pehrsson, 1984, Cardiac performance in various stages of renal failure, Br. Heart J., 52, 667, 10.1136/hrt.52.6.667

Gyurászová, M., Kovalčíková, A.G., Renczés, E., Kmeťová, K., Celec, P., Bábíčková, J., and Tóthová, L. (2019). Oxidative Stress in Animal Models of Acute and Chronic Renal Failure. Dis. Markers.

Stevenson, 2006, Retinopathy Is Reduced during Experimental Diabetes in a Mouse Model of Outer Retinal Degeneration, Investig. Ophthalmol. Vis. Sci., 47, 5561, 10.1167/iovs.06-0647

Uchiki, 2012, Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in non diabetics), Aging Cell, 11, 1, 10.1111/j.1474-9726.2011.00752.x

Hegab, 2012, Role of advanced glycation end products in cardiovascular disease, World J. Cardiol., 4, 90, 10.4330/wjc.v4.i4.90

Gkogkolou, 2012, Advanced glycation end products: Key players in skin aging?, Derm. Endocrinol., 3, 259, 10.4161/derm.22028

Sell, 1990, End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen, J. Clin. Investig., 85, 380, 10.1172/JCI114449

Chatzigeorgiou, 2013, Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats, J. Endocrinol., 218, 331, 10.1530/JOE-13-0175

Mondal, 2018, Biochemical scenario behind initiation of diabetic retinopathy in type 2 diabetes mellitus, Indian J. Ophthalmol., 66, 535, 10.4103/ijo.IJO_1121_17

Bucala, 1994, Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency, Proc. Natl. Acad. Sci. USA, 91, 9441, 10.1073/pnas.91.20.9441

Rhee, 2018, The Role of Advanced Glycation End Products in Diabetic Vascular Complications, Diabetes Metab. J., 42, 188, 10.4093/dmj.2017.0105

Smith, 2017, The false alarm hypothesis: Food allergy is associated with high dietary advanced glycation end-products and proglycating dietary sugars that mimic alarmins, J. Allergy Clin. Immunol., 139, 429, 10.1016/j.jaci.2016.05.040

Smith, 2017, Do advanced glycation end-products cause food allergy?, Curr. Opin. Allergy Clin. Immunol., 17, 325, 10.1097/ACI.0000000000000385

Forbes, 2005, Below the radar: Advanced glycation end products that detour “around the side”. Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes?, Clin. Biochem. Rev., 26, 123

Dozio, 2017, Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation, Mediat. Inflamm., 2017, 9845175, 10.1155/2017/9845175

Kanda, 2017, Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy, Sci. Rep., 7, 16168, 10.1038/s41598-017-16499-8

Wada, 2005, Role of advanced glycation end products and their receptors in development of diabetic neuropathy, Ann. N. Y. Acad. Sci., 1043, 598, 10.1196/annals.1338.067

Normand, 2018, AGE Content of a Protein Load Is Responsible for Renal Performances: A Pilot Study, Diabetes Care, 41, 1292, 10.2337/dc18-0131

Nakashima, 2014, Linagliptin blocks renal damage in type 1 diabetic rats by suppressing advanced glycation end products-receptor axis, Horm. Metab. Res., 46, 717, 10.1055/s-0034-1371892

Nakamura, 1993, Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus, Am. J. Pathol., 143, 1649

Manicam, 2017, Compensatory Vasodilator Mechanisms in the Ophthalmic Artery of Endothelial Nitric Oxide Synthase Gene Knockout Mice, Sci. Rep., 7, 7111, 10.1038/s41598-017-07768-7

Bucala, 1993, Lipid advanced glycosylation: Pathway for lipid oxidation in vivo, Proc. Natl. Acad. Sci. USA, 90, 6434, 10.1073/pnas.90.14.6434

Teissier, 2019, Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions, Aging Cell, 18, e12850, 10.1111/acel.12850

Vitek, 1994, Advanced glycation end products contribute to amyloidosis in Alzheimer disease, Proc. Natl. Acad. Sci. USA, 91, 4766, 10.1073/pnas.91.11.4766

Rutkowska, 2016, Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?, Curr. Pharm. Des., 22, 5558, 10.2174/1381612822666160714094404

Katsikis, 2008, Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS), Clin. Endocrinol., 69, 634, 10.1111/j.1365-2265.2008.03247.x

Garg, 2016, Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS, Reprod. Biol. Endocrinol., 14, 71, 10.1186/s12958-016-0205-6

Tantalaki, 2014, Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS), Hormones, 13, 65, 10.1007/BF03401321

Merhi, 2019, Implications and Future Perspectives of AGEs in PCOS Pathophysiology, Trends Endocrinol. Metab., 30, 150, 10.1016/j.tem.2019.01.005

Lin, P.H., Chang, C.C., Wu, K.H., Shih, C.K., Chiang, W., Chen, H.Y., Shih, Y.H., Wang, K.L., Hong, Y.H., and Shieh, T.M. (2019). Dietary Glycotoxins, Advanced Glycation End Products, Inhibit Cell Proliferation and Progesterone Secretion in Ovarian Granulosa Cells and Mimic PCOS-like Symptoms. Biomolecules, 9.

Liao, 2017, An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients, Reprod. Biol. Endocrinol., 15, 1, 10.1186/s12958-017-0227-8

Lambrinoudaki, 2010, Androgens associated with advanced glycation end-products in postmenopausal women, Menopause, 17, 1182, 10.1097/gme.0b013e3181e170af

Li, 2005, Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome, Zhonghua Yi Xue Za Zhi, 85, 3266

Stracquadanio, 2018, Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women, Gynecol. Endocrinol., 34, 223, 10.1080/09513590.2017.1381838

Papachroni, 2010, Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue, J. Cell. Mol. Med., 14, 2460, 10.1111/j.1582-4934.2009.00841.x

Graff, 2013, Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes, Fertil. Sterl., 100, 1081, 10.1016/j.fertnstert.2013.06.005

Irani, 2014, Role of vitamin D in ovarian physiology and its implications in reproduction: A systematic review, Fertil. Sterl., 102, 460, 10.1016/j.fertnstert.2014.04.046

Masjedi, 2019, Effects of vitamin D on steoidogenesis, reactive oxygen species production, and enzymatic antioxidant defense in human granulose cells of normal and polycystic ovaries, J. Steroid Biochem. Mol. Biol., 197, 105521, 10.1016/j.jsbmb.2019.105521

Endo, 2006, Significance of matrix metalloproteinases in pathophysiology of the ovary and uterus, Reprod. Med. Biol., 5, 235, 10.1111/j.1447-0578.2006.00147.x

Merhi, 2019, Vitamin D attenuates the effect of advanced glycation end products on anti-Mullerian hormone signaling, Mol. Cell. Endocrinol., 479, 87, 10.1016/j.mce.2018.09.004

Henmi, H., Endo, T., Nagasawa, K., Hayashi, T., Chida, M., Akutagawa, N., Iwasaki, M., Kitajima, Y., Kiya, T., and Nishikawa, A. (2001). Lysyl oxidase and MMP-2 expression in dehydorepiandrosterone-induces polycystic ovary in rats. Biology of Reproduction. 64, 157–162.

Christakou, 2014, Polycystic ovary syndrome-phenotype and diagnosis. Scandinavian journal of clinical and laboratory investigation, Supplementum, 244, 18

Livadas, 2013, Polycystic ovary syndrome: Definitions, phenotypes and diagnostic approach, Front. Horm. Res., 40, 1, 10.1159/000341673

Macut, D., Mladenovic, V., Bjekic-Macut, J., Livadas, S., Stanojlovic, O., Hrncic, D., Rasic-Markovic, A., Milutinovic, D.V., and Andric, Z. (2019). Hypertension in polycystic ovary syndrome: Novel insights. Curr. Hypertens. Rev.

Merhi, 2018, Advanced glycation end products alter steroidogenic gene expression by granulosa cells: An effect partially reversible by vitamin D, Mol. Hum. Reprod., 24, 318, 10.1093/molehr/gay014

Piperi, 2006, Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome, Metab. Clin. Exp., 55, 494, 10.1016/j.metabol.2005.10.011

Piperi, 2007, Accumulation of dietary glycotoxins in the reproductive system of normal female rats, J. Mol. Med., 85, 1413, 10.1007/s00109-007-0246-6

Merhi, 2019, Crosstalk between advanced glycation end products and vitamin D: A compelling paradigm for the treatment of ovarian dysfunction in PCOS, Mol. Cell. Endocrinol., 479, 20, 10.1016/j.mce.2018.08.010

Koenders, 2018, Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study, PLoS ONE, 13, e0204748, 10.1371/journal.pone.0204748

Lin, 2015, The role of vitamin D in polycystic ovary syndrome, Indian J. Med. Res., 142, 238, 10.4103/0971-5916.166527

Heilmann, 2014, Ovalbumin modified with pyrraline, a Maillard reaction product, shows enhanced T-cell immunogenicity, J. Biol. Chem., 289, 7919, 10.1074/jbc.M113.523621

Kellow, 2015, Effect of diet-derived advanced glycation end products on inflammation, Nutr. Rev., 73, 737, 10.1093/nutrit/nuv030

Akram, Z., Alqahtani, F., Alqahtani, M., Al-Kheraif, A.A., and Javed, F. (2019). Levels of advanced glycation end products in gingival crevicular fluid of chronic periodontitis patients with and without type-2 diabetes mellitus. J. Periodontol.